EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gene Therapy Approaches for the Treatment of Hemophilia B

Anastasiia B Soroka iD, Sofya G Feoktistova iD, Olga N Mityaeva, Pavel Y Volchkov iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241310766 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anastasiia B Soroka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Life Sciences Research Center, Moscow Institute of Physics and Technology, National Research University, 141700 Dolgoprudniy, Russia. Hauptthemen laut MEDLINE: Hemophilia B, Hemophilia A. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In contrast to the standard enzyme-replacement therapy, administered from once per 7–14 days to 2–3 times a week in patients with severe hemophilia B, as a result of a single injection, gene therapy can restore F9 gene expression and maintain it for a prolonged time. In clinical research, the approach of delivering a functional copy of a gene using adeno-associated viral (AAV) vectors is widely used. The scientific community is actively researching possible modifications to improve delivery efficiency and expression. In preclinical studies, the possibility of genome editing using CRISPR/Cas9 technology for the treatment of hemophilia B is also being actively studied.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia BHemophilia AHumansFactor IXGenetic VectorsGenetic TherapyDependovirus

Stichwörter der Autor:innen

AAVblood coagulation factor IXgene therapygenome editinghemophilia Bhemostasis

Substanzen

Factor IX

Autor:innen und Institutionen

  • Life Sciences Research Center, Moscow Institute of Physics and Technology, National Research University, 141700 Dolgoprudniy, Russia.

ORCID-Profile: Anastasiia B Soroka, Sofya G Feoktistova, Pavel Y Volchkov

Förderung

  • Russian Science Foundation

Zitieren

APA

Soroka, A. B., Feoktistova, S. G., Mityaeva, O. N., & Volchkov, P. Y. (2023). Gene Therapy Approaches for the Treatment of Hemophilia B. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310766

Vancouver

Soroka AB, Feoktistova SG, Mityaeva ON, Volchkov PY. Gene Therapy Approaches for the Treatment of Hemophilia B. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310766

BibTeX
@article{Soroka2023,
  author = {Soroka, Anastasiia B and Feoktistova, Sofya G and Mityaeva, Olga N and Volchkov, Pavel Y},
  title = {Gene Therapy Approaches for the Treatment of Hemophilia B},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241310766}
}
Kostenlos starten →